STOCK TITAN

CareCloud (CCLD) SEC Filings

CCLD NASDAQ

CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.

CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.

Rhea-AI Summary

CareCloud, Inc. (CCLD) reported third-quarter 2026 revenue of $33.725 million, compared with $31.067 million in 2025, and net income of $4.727 million versus $3.060 million. For the first nine months, revenue was $96.875 million versus $86.076 million, while net income was $6.771 million versus $7.910 million; operating cash flow was $16.327 million versus $19.886 million.

In April 2026, CareCloud entered a credit facility with a $40 million term loan and a $10 million revolving line. At September 30, 2026, the term loan balance was approximately $36.7 million, no borrowings were outstanding on the revolving line, and CareCloud reported compliance with all covenants. Approximately $41.6 million of facility borrowings funded the May 15, 2026 redemption of Series B preferred stock at $27.52 per share. A separate at-the-market program permits up to $60 million of common-stock sales; no sales had occurred.

A March 16, 2026 cybersecurity incident affected one of six electronic health record environments for approximately eight hours. The investigation found that an unauthorized third party accessed a supporting cloud account and exfiltrated patient-related information; affected systems were restored, with no evidence of incident-related unauthorized activity after March 16, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.48%
Tags
quarterly report
-
Rhea-AI Summary

CareCloud, Inc. (CCLD) reported record third-quarter 2026 results: GAAP net income was $4.7 million, up 54% year over year; diluted GAAP EPS was $0.10, up 150%; and adjusted EBITDA was $9.9 million, up 28%. Revenue increased to $33.725 million from $31.067 million. Revenue less direct operating costs rose to 50.5% of revenue from 47.8%.

For the first nine months, GAAP net income was $6.771 million versus $7.910 million, and operating cash flow was $16.327 million versus $19.886 million. CareCloud reaffirmed 2026 guidance of $128–$132 million in revenue, $29–$31 million in adjusted EBITDA and $0.20–$0.23 in GAAP EPS; achieving guidance depends in part on continued performance of existing and new customers. During the nine months, the company reported $39.756 million in term-loan proceeds, $3.874 million in term and other loan repayments, and $38.169 million for Series B preferred-stock redemption.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.00%
Tags
current report
-
Rhea-AI Summary

CareCloud, Inc. names Bonnie Alice Boyer, its Chief Financial Officer, as the reporting person in a Form 3 beneficial ownership statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
insider
Rhea-AI Summary

CareCloud, Inc. appointed Bonnie Boyer Chief Financial Officer effective October 1, 2026, succeeding Norman Roth, who will transition from Interim Chief Financial Officer to Advisor to the CEO on that date. Boyer joined CareCloud as Assistant Chief Financial Officer on July 9, 2026, and has more than 15 years of finance leadership experience.

Her employment agreement, effective October 1, provides an annual base salary of $300,000 and eligibility for an annual target bonus equal to 30% of base salary. Termination without cause provides six months of salary continuation and company-paid COBRA premiums; nonrenewal provides six months of base salary as severance. If employment ends in connection with a change of control, salary continuation covers the remainder of the term, but not less than 24 months, at base salary plus target bonus, with COBRA premiums for the same period. These payments require a release of claims and continued compliance with non-competition and non-solicitation obligations. CareCloud stated 2026 revenue guidance of approximately $130 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
current report
-
Rhea-AI Summary

CareCloud, Inc. director Anne Busquet reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of Common Stock on August 8, 2026. The RSUs and resulting shares were acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person. Following the transaction, Busquet directly held 308,888 shares of common stock and 37,500 Restricted Stock Units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
insider
-
Rhea-AI Summary

CareCloud, Inc. director Bill Korn reported the vesting and conversion of 7,500 Restricted Stock Units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by Korn. Following this transaction, Korn directly holds 225,383 shares of common stock and 37,500 Restricted Stock Units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
insider
Rhea-AI Summary

CareCloud, Inc. director Cameron Munter reported the vesting and conversion of 7,500 Restricted Stock Units into 7,500 shares of common stock on August 8, 2026. The equity was acquired under the company’s Amended and Restated Equity Incentive Plan without payment by the reporting person, leaving 216,500 common shares held directly and 37,500 RSUs outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
insider
-
Rhea-AI Summary

CareCloud, Inc. director Lawrence Steven Sharnak reported the vesting and conversion of 7,500 restricted stock units into an equal number of shares of common stock on August 8, 2026. The RSUs and resulting shares were issued under the company’s Amended and Restated Equity Incentive Plan without payment by him. Following these transactions, he held 141,500 shares of common stock directly and 37,500 restricted stock units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
insider
-
Rhea-AI Summary

CareCloud, Inc. reported Q2 2026 net revenue of $31.9 million, up from $27.4 million a year earlier, driven mainly by Healthcare IT services and contributions from recent acquisitions including Medsphere, RevNu, MAP App and Empower. Six‑month revenue reached $63.2 million versus $55.0 million in 2025.

Operating income declined to $1.9 million in Q2 and $2.9 million year‑to‑date, with net income of $1.1 million for the quarter and $2.0 million for six months. After $2.3 million of preferred dividends, six‑month earnings attributable to common shareholders were a small loss of $0.3 million. Cash increased to $13.4 million, while total liabilities rose to $76.4 million, reflecting a new credit facility with a $40 million term loan and $10 million revolver, of which $39.2 million and $9.0 million were outstanding and used largely to fund a roughly $41.6 million redemption of all Series B Preferred Stock.

The company continued to amortize $107.3 million of intangible assets and carried $31.8 million of goodwill tied to its acquisition strategy. In March 2026 it experienced a cybersecurity incident that briefly disrupted one electronic health record environment and involved exfiltration of patient information; multiple class actions have been consolidated, and management believes cyber insurance will cover most related costs apart from a $100,000 retention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.36%
Tags
quarterly report
Rhea-AI Summary

CareCloud, Inc. reported Q2 2026 revenue of $31.9 million, up from $27.4 million in Q2 2025, marking its ninth consecutive quarter of positive GAAP net income. GAAP net income was $1.1 million versus $2.9 million a year ago, and GAAP EPS was $0.00 versus $0.04. Adjusted EBITDA was $5.9 million compared with $6.5 million. Year-to-date, revenue reached $63.2 million versus $55.0 million, with GAAP net income of $2.0 million versus $4.9 million and adjusted EBITDA of $11.3 million versus $12.1 million.

The company completed the acquisition of Empower Healthcare & Compliance Partners, entering the compliance and audit-defense market for its network of more than 40,000 providers, and fully redeemed all Series B Preferred Stock on May 15, 2026. During the first half, it received $39.7 million in term-loan proceeds and $9.0 million from its line of credit and used $38.2 million to redeem the Series B, contributing to interest expense of $0.8 million versus $0.1 million in the prior-year quarter.

Cash increased to $13.4 million from $3.1 million at December 31, 2025, while total liabilities were $76.4 million and shareholders’ equity $17.4 million. Free cash flow for the first half of 2026 was $8.1 million versus $9.1 million a year earlier. Management reaffirmed full-year 2026 guidance for revenue of $128–$132 million, adjusted EBITDA of $29–$31 million, and GAAP EPS of $0.20–$0.23.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.66%
Tags
current report

FAQ

How many CareCloud (CCLD) SEC filings are available on StockTitan?

StockTitan tracks 53 SEC filings for CareCloud (CCLD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CareCloud (CCLD)?

The most recent SEC filing for CareCloud (CCLD) was filed on November 5, 2026.